Literature DB >> 29358024

The association between relevant co-morbidities and prevalent as well as incident heart failure in patients with atrial fibrillation.

Per Wändell1, Axel C Carlsson2, Martin J Holzmann3, Johan Ärnlöv4, Jan Sundquist5, Kristina Sundquist5.   

Abstract

BACKGROUND: Congestive heart failure (CHF) is a serious complication in patients with atrial fibrillation (AF).
OBJECTIVE: To study associations between relevant co-morbidities and CHF in patients with AF.
METHODS: Study population included all adults (n=12,283) ≥45 years diagnosed with AF at 75 primary care centers in Sweden 2001-2007. Logistic regression was used to calculate odds ratios with 95% confidence intervals (CIs) for the associations between co-morbidities, and prevalent CHF. In a subsample (n=9424), (excluding patients with earlier CHF), Cox regression was used to estimate hazard ratios with 95% CIs for the association between co-morbidities, and a first hospital diagnosis of CHF, after adjustment for age and socio-economic factors.
RESULTS: During 5.4 years' follow-up (standard deviation 2.5), 2259 patients (24.0%; 1135 men, 21.8%, and 1124 women, 26.7%) were diagnosed with CHF. Patients with hypertension were less likely to have CHF, while a diagnosis of coronary heart disease, valvular heart disease, diabetes, or chronic obstructive pulmonary disease (COPD), was consistently associated with CHF among men and women. CHF was more common among women with depression. The relative fully adjusted risk of incident CHF was increased for the following diseases in men with AF: valvular heart disease, cardiomyopathy, and diabetes; and for the following diseases in women: valvular heart disease, diabetes, obesity, and COPD. The corresponding risk was decreased among women for hypertension.
CONCLUSIONS: In this clinical setting we found hypertension to be associated with a decreased risk of CHF among women; valvular heart disease and diabetes to be associated with an increased risk of CHF in both sexes; and cardiomyopathy to be associated with an increased risk of CHF among men.
Copyright © 2018 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Congestive heart failure; Gender; Hypertension

Mesh:

Year:  2018        PMID: 29358024      PMCID: PMC5971120          DOI: 10.1016/j.jjcc.2017.12.010

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  26 in total

1.  Modifiable Risk Factors for Incident Heart Failure in Atrial Fibrillation.

Authors:  Neal A Chatterjee; Claudia U Chae; Eunjung Kim; M Vinayaga Moorthy; David Conen; Roopinder K Sandhu; Nancy R Cook; I-Min Lee; Christine M Albert
Journal:  JACC Heart Fail       Date:  2017-06-14       Impact factor: 12.035

Review 2.  Chronic Obstructive Pulmonary Disease and Cardiac Diseases. An Urgent Need for Integrated Care.

Authors:  Sara Roversi; Leonardo M Fabbri; Don D Sin; Nathaniel M Hawkins; Alvar Agustí
Journal:  Am J Respir Crit Care Med       Date:  2016-12-01       Impact factor: 21.405

3.  Temporal trends in clinical characteristics, management and prognosis of patients with symptomatic heart failure in Japan -- report from the CHART Studies.

Authors:  Ryoichi Ushigome; Yasuhiko Sakata; Kotaro Nochioka; Satoshi Miyata; Masanobu Miura; Soichiro Tadaki; Takeshi Yamauchi; Kenjiro Sato; Takeo Onose; Kanako Tsuji; Ruri Abe; Takuya Oikawa; Shintaro Kasahara; Jun Takahashi; Hiroaki Shimokawa
Journal:  Circ J       Date:  2015-09-10       Impact factor: 2.993

4.  Decreasing trends in the incidence of heart failure after acute myocardial infarction from 1993-2004: a study of 175,216 patients with a first acute myocardial infarction in Sweden.

Authors:  Masoud Shafazand; Annika Rosengren; Georgios Lappas; Karl Swedberg; Maria Schaufelberger
Journal:  Eur J Heart Fail       Date:  2010-11-30       Impact factor: 15.534

5.  No decline in the risk of heart failure after incident atrial fibrillation: A community study assessing trends overall and by ejection fraction.

Authors:  Alanna M Chamberlain; Bernard J Gersh; Alvaro Alonso; Stephen L Kopecky; Jill M Killian; Susan A Weston; Véronique L Roger
Journal:  Heart Rhythm       Date:  2017-01-21       Impact factor: 6.343

6.  Effects of prescribed antihypertensives and other cardiovascular drugs on mortality in patients with atrial fibrillation and hypertension: a cohort study from Sweden.

Authors:  Axel C Carlsson; Per Wändell; Kristina Sundquist; Sven-Erik Johansson; Jan Sundquist
Journal:  Hypertens Res       Date:  2014-03-06       Impact factor: 3.872

Review 7.  Sleep Apnea and Cardiovascular Disease: Lessons From Recent Trials and Need for Team Science.

Authors:  Luciano F Drager; R Doug McEvoy; Ferran Barbe; Geraldo Lorenzi-Filho; Susan Redline
Journal:  Circulation       Date:  2017-11-07       Impact factor: 29.690

8.  Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study.

Authors:  Jeff S Healey; Jonas Oldgren; Michael Ezekowitz; Jun Zhu; Prem Pais; Jia Wang; Patrick Commerford; Petr Jansky; Alvaro Avezum; Alben Sigamani; Albertino Damasceno; Paul Reilly; Alex Grinvalds; Juliet Nakamya; Akinyemi Aje; Wael Almahmeed; Andrew Moriarty; Lars Wallentin; Salim Yusuf; Stuart J Connolly
Journal:  Lancet       Date:  2016-08-08       Impact factor: 79.321

Review 9.  European Primary Care Cardiovascular Society (EPCCS) consensus guidance on stroke prevention in atrial fibrillation (SPAF) in primary care.

Authors:  Fd Richard Hobbs; Clare J Taylor; Geert Jan Geersing; Frans H Rutten; Judith R Brouwer
Journal:  Eur J Prev Cardiol       Date:  2015-02-20       Impact factor: 7.804

Review 10.  Epidemiology of atrial fibrillation: European perspective.

Authors:  Massimo Zoni-Berisso; Fabrizio Lercari; Tiziana Carazza; Stefano Domenicucci
Journal:  Clin Epidemiol       Date:  2014-06-16       Impact factor: 4.790

View more
  9 in total

1.  Association Between Relevant Co-Morbidities and Dementia With Atrial Fibrillation-A National Study.

Authors:  Per Wändell; Axel C Carlsson; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  Arch Med Res       Date:  2019-05-31       Impact factor: 2.235

2.  Associations between relevant cardiovascular pharmacotherapies and incident heart failure in patients with atrial fibrillation: a cohort study in primary care.

Authors:  Per Wändell; Axel C Carlsson; Martin J Holzmann; Johan Ärnlöv; Jan Sundquist; Kristina Sundquist
Journal:  J Hypertens       Date:  2018-09       Impact factor: 4.844

3.  The association between gout and cardiovascular disease in patients with atrial fibrillation.

Authors:  Per Wändell; Axel C Carlsson; Jan Sundquist; Kristina Sundquist
Journal:  SN Compr Clin Med       Date:  2019-01-28

4.  Allostatic load in the association of depressive symptoms with incident coronary heart disease: The Jackson Heart Study.

Authors:  Shannon L Gillespie; Cindy M Anderson; Songzhu Zhao; Yubo Tan; David Kline; Guy Brock; James Odei; Emily O'Brien; Mario Sims; Sophie A Lazarus; Darryl B Hood; Karen Patricia Williams; Joshua J Joseph
Journal:  Psychoneuroendocrinology       Date:  2019-07-04       Impact factor: 4.905

5.  Use of cardiovascular drugs and risk of incident heart failure in patients with atrial fibrillation.

Authors:  Per Wändell; Axel C Carlsson; Xinjun Li; Martin J Holzmann; Jan Sundquist; Kristina Sundquist
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-07-15       Impact factor: 3.738

6.  Value of peripheral blood neutrophil-to-lymphocyte ratio for clinical diagnosis and prognosis of elderly patients with chronic heart failure and atrial fibrillation.

Authors:  Chentao Yang; Hua Yang; Sufang Feng; Jie Qin
Journal:  Cardiovasc J Afr       Date:  2021-03-02       Impact factor: 1.167

7.  Patients with atrial fibrillation and permanent pacemaker: Temporal changes in patient characteristics and pharmacotherapy.

Authors:  Frederik Dalgaard; Martin H Ruwald; Tommi Bo Lindhardt; Gunnar H Gislason; Christian Torp-Pedersen; Jannik L Pallisgaard
Journal:  PLoS One       Date:  2018-03-28       Impact factor: 3.240

Review 8.  Diabetes mellitus and risk of new-onset and recurrent heart failure: a systematic review and meta-analysis.

Authors:  Satoru Kodama; Kazuya Fujihara; Chika Horikawa; Takaaki Sato; Midori Iwanaga; Takaho Yamada; Kiminori Kato; Kenichi Watanabe; Hitoshi Shimano; Tohru Izumi; Hirohito Sone
Journal:  ESC Heart Fail       Date:  2020-07-29

9.  Association of proteinuria with incident atrial fibrillation in the general Japanese population.

Authors:  Yoshihiro Tanaka; Hayato Tada; Satoshi Hara; Kenshi Hayashi; Ravi B Patel; Tetsuo Nishikawa; Atsushi Hashiba; Masayuki Takamura; Philip Greenland; Masa-Aki Kawashiri
Journal:  J Cardiol       Date:  2020-08-23       Impact factor: 3.159

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.